U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 22:51:22 GMT 2025
Edited
by admin
on Mon Mar 31 22:51:22 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
5FJL6W0640
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CABIRALIZUMAB
INN   WHO-DD  
INN  
Official Name English
cabiralizumab [INN]
Preferred Name English
IMMUNOGLOBULIN G4, ANTI-(MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL FPA008 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL FPA008 LIGHT CHAIN, DIMER
Common Name English
Cabiralizumab [WHO-DD]
Common Name English
FPA008
Common Name English
FPA-008
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
FDA ORPHAN DRUG 502315
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
EU-Orphan Drug EU/3/16/1799
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
Code System Code Type Description
SMS_ID
100000174820
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
PRIMARY
NCI_THESAURUS
C123831
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
PRIMARY
DRUG BANK
DB15082
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
PRIMARY
INN
10121
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
PRIMARY
CAS
1613144-80-1
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
PRIMARY
FDA UNII
5FJL6W0640
Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025
PRIMARY
From To
1_22 1_96
1_149 1_205
1_263 1_323
1_369 1_427
2_22 2_96
2_149 2_205
2_263 2_323
2_369 2_427
1_136 3_218
2_136 4_218
1_228 2_228
1_231 2_231
3_23 3_92
3_138 3_198
4_23 4_92
4_138 4_198
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR
TARGET -> INHIBITOR
Related Record Type Details
CABIRALIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966